NDC 71872-7144 – Lidocaine Hydrochloride
Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural
Product NDC71872-7144
Product details
- Brand name
- Lidocaine Hydrochloride
- Generic name
- Lidocaine Hydrochloride
- Labeler
- Medical Purchasing Solutions, LLC
- Dosage form
- Injection, Solution
- Route
- Epidural, Infiltration, Intracaudal, Perineural
- Marketing category
- ANDA · ANDA203082
- Marketed since
- March 14, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Active ingredients
- Lidocaine Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Lidocaine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71872-7144-1 | 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7144-1) / 5 mL in 1 VIAL, SINGLE-DOSE | Sep 24, 2018 |
Other Lidocaine Hydrochloride products
- 50090-0258 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · A-S Medication Solutions
- 80425-0268 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · Advanced Rx Pharmacy of Tennessee, LLC
- 83854-012 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 83854-011 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 83854-009 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 83854-010 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 76420-756 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-078 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-540 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-079 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-080 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · Asclemed USA, Inc.
- 76420-084 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · Asclemed USA, Inc.